Non-viral chimeric antigen receptor (CAR)-T cells are gaining attention for their cancer-killing ability with reduced side effects. Traditional CAR-T cell engineering relies on lentivirus, which causes random chromosomal integration, permanent CAR expression, and adverse effects from persistent immunologic stimulation. To
5% off ELISA Kits for Cancer Biomarkers
Get 5% off Cloud-Clone’s cancer biomarker ELISA kits until 31st December 2024! Contact us with promo code ‘CLOUD5Q3’ to redeem this offer.
Cancer Research Tools by Caltag Medsystems
With 1 person dying of cancer every 4 minutes, there is a need for more research. Explore our cancer research products to help change these statistics.
VivoVist™ – The Ultimate X-ray Contrast Agent for Micro CT
VivoVist™ is a revolutionary nanotechnology super contrast agent of alkaline earth metal nanoparticles for enhanced X-ray imaging in microCT.
Cervical cancer is the fourth most common cancer affecting women: Antigen-Specific Detection of HPV and HSV
Cervical cancer is the 4th most prevalent cancer among women, and the 7th most common cancer. MBLI provides HPV-related tetramers for use in research.
Rapid and Reliable Custom Tetramer Generation for T-Cell Staining
MBLI QuickSwitch™ kit technology aims to replicate the immune response by mimicking peptide exchange on an MHC molecule.
Advancements in the understanding of m7G Modification
There is more data that highlights the significant role of m7G modification in human diseases, particularly cancer.
The Impact of In Vivo Isotype Controls on Therapeutic Drug Development
In vivo antibody studies offer a wide range of applications. Discover the significant impact of antibody selection on your experiment.
Explore the Limitless Potential of IL-18
Researchers take advantage of MBL International’s recombinant IL-18 to activate varying cells like peripheral blood cells, macrophages, NK cells and T cells to identify targets.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.